文献速递肺血管病与心包/心肌炎心力衰竭与心肌病

肺动脉高压与心力衰竭中的心肺血流动力学:JACC每周综述

Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

肺动脉高压是尤其左心疾病患者不良临床结局的独立危险因素。新证据支持将平均肺动脉压>20 mmHg纳入循证定义并强调早期诊断,肺血管阻力2.2-3.0 WU与临床风险升高相关。修订后的分类将患者分为毛细血管前、单纯毛细血管后或合并毛细血管前/后肺动脉高压,指导床旁诊断、风险分层和治疗。

要点

  • 新定义强调mPAP>20 mmHg即异常并关联临床事件,应重视早期诊断。
  • PVR 2.2-3.0 WU既往视为正常,现提示临床风险升高。
  • 修订分类(毛细血管前/单纯毛细血管后/合并)指导诊断与治疗决策。

核心结论

  • 肺动脉高压是左心疾病患者不良临床结局的独立危险因素。
  • 基于证据的新定义将mPAP>20 mmHg纳入并强调早期诊断。
  • PVR 2.2-3.0 WU与临床风险升高相关。
  • 修订后的血流动力学分类指导床旁诊断、风险分层和治疗。

研究设计与样本

  • 本文为JACC综述,未报告系统检索范围或样本量。

主要发现

  • 近期进展明确了高于正常且与临床事件(包括死亡)相关的mPAP范围。
  • PVR 2.2-3.0 WU(既往认为正常)似与临床风险升高相关。
  • 运动血流动力学或液体负荷试验可能有助于肺动脉高压-左心疾病或不明原因呼吸困难的决策。

关键数值与推荐

  • 肺动脉高压新定义纳入mPAP>20 mmHg。
  • PVR 2.2-3.0 WU提示临床风险升高。
  • 分类为毛细血管前、单纯毛细血管后或合并毛细血管前/后肺动脉高压。

临床怎么用

  • 对左心疾病患者应关注肺动脉高压的血流动力学评估。
  • 采用mPAP>20 mmHg和PVR 2.2-3.0 WU识别高风险患者。
  • 按修订分类进行床旁诊断、风险分层和治疗决策。
  • 对肺动脉高压-左心疾病或不明原因呼吸困难可考虑运动血流动力学或液体负荷试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pulmonary hypertension (PH) is an independent risk factor for adverse clinical outcome, particularly in left heart disease (LHD) patients. Recent advances have clarified the mean pulmonary artery pressure (mPAP) range that is above normal and is associated with clinical events, including mortality. This progress has for the first time resulted in a new clinical definition of PH that is evidenced-based, is inclusive of mPAP >20 mm Hg, and emphasizes early diagnosis. Additionally, pulmonary vascular resistance (PVR) 2.2 to 3.0 WU, considered previously to be normal, appears to associate with elevated clinical risk. A revised approach to classifying PH patients as pre-capillary, isolated post-capillary, or combined pre-/post-capillary PH now guides point-of-care diagnosis, risk stratification, and treatment. Exercise hemodynamic or confrontational fluid challenge studies may also aid decision-making for patients with PH-LHD or otherwise unexplained dyspnea. This collective progress in pulmonary vascular and heart failure medicine reinforces the critical importance of accurate hemodynamic assessment.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Maron BA, Kovacs G, Vaidya A, et al. Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2020. PMID: 33243385. doi:10.1016/j.jacc.2020.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。